72 related articles for article (PubMed ID: 232847)
21. Concentration of 25-hydroxyvitamin D in serum of infants under the intermittent high-dose vitamin D3 prophylactic treatment.
Pietrek J; Otto-Buczkowska E; Kokot F; Karpiel R; Cekański A
Arch Immunol Ther Exp (Warsz); 1980; 28(5):805-14. PubMed ID: 6260055
[TBL] [Abstract][Full Text] [Related]
22. 25-hydroxycholecalciferol-enhanced bone maturation in the parathyroprivic state.
Russell JE; Avioli LV
J Clin Invest; 1975 Oct; 56(4):792-8. PubMed ID: 1159088
[TBL] [Abstract][Full Text] [Related]
23. [Rickets prophylaxis by daily administration of vitamin D tablets (author's transl)].
Gemeiner M; Pilz I; Swoboda W
Wien Med Wochenschr; 1979 May; 129(9):237-40. PubMed ID: 442683
[TBL] [Abstract][Full Text] [Related]
24. Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion.
Reginster JY; Zegels B; Lejeune E; Micheletti MC; Taquet AN; Albert A
Gynecol Endocrinol; 2001 Feb; 15(1):56-62. PubMed ID: 11293926
[TBL] [Abstract][Full Text] [Related]
25. [Cholecalciferol metabolism of pregnant rats with vitamin D poisoning].
Lazareva NP; Petrova EA
Vopr Pitan; 1982; (2):42-4. PubMed ID: 6283737
[TBL] [Abstract][Full Text] [Related]
26. [Direct stimulatory action of blood serum, vitamin D3, and its hydroxy-analogs on calcium transport in the small intestine of chicks in vitro].
Bauman VK; Andrushaite RE; Berzin' NI; Valinietse MIu; Val'dman AR
Biull Eksp Biol Med; 1980 Dec; 90(12):683-6. PubMed ID: 6258667
[TBL] [Abstract][Full Text] [Related]
27. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women.
Tjellesen L; Hummer L; Christiansen C; Rødbro P
Bone Miner; 1986 Oct; 1(5):407-13. PubMed ID: 2849489
[TBL] [Abstract][Full Text] [Related]
28. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
[TBL] [Abstract][Full Text] [Related]
29. Effect of oral vitamin D, 25-hydroxycholecalciferol (25-HCC) and whole-body ultra-violet irradiation on plasma 25-HCC levels in man.
Stamp TC; Round JM; Haddad JG
Clin Sci; 1973 Feb; 44(2):3P-4P passim. PubMed ID: 4723279
[No Abstract] [Full Text] [Related]
30. Inhibition of the in vitro growth of Plasmodium falciparum by D vitamins and vitamin D-3 derivatives.
Vial HJ; Thuet MJ; Philippot JR
Mol Biochem Parasitol; 1982 Mar; 5(3):189-98. PubMed ID: 6283344
[TBL] [Abstract][Full Text] [Related]
31. Serum concentrations of 25-hydroxy vitamin D in Europeans and Asians after oral vitamin D3.
Ellis G; Cooke WT
Br Med J; 1978 Mar; 1(6114):685-6. PubMed ID: 204391
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and amounts of 25-hydroxycholecalciferol in sheep affected by osteodystrophy.
Hidiroglou M; Williams CJ; Ivan M
J Dairy Sci; 1979 Apr; 62(4):567-71. PubMed ID: 222820
[TBL] [Abstract][Full Text] [Related]
33. Effect of an oral dose of 25-hydroxyvitamin D3 on its blood levels in patients with the nephrotic syndrome.
Haldimann B; Healy M; Jelliffe R; Goldstein DA; Pattabhiraman R; Massry SG
J Clin Endocrinol Metab; 1980 Mar; 50(3):470-4. PubMed ID: 7358832
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in man.
Offermann G; Schaefer K; Grigoleit HG; Dittmar F
Eur J Clin Pharmacol; 1975 Apr; 8(3-4):255-60. PubMed ID: 1233221
[TBL] [Abstract][Full Text] [Related]
35. Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol.
Haddad JG; Hillman L; Rojanasathit S
J Clin Endocrinol Metab; 1976 Jul; 43(1):86-91. PubMed ID: 1084889
[TBL] [Abstract][Full Text] [Related]
36. 25-OHD3-26,23-lactone: a metabolite of vitamin D3 that is 5 times more potent than 25-OHD3 in the rat plasma competitive protein binding radioassay.
Horst RL
Biochem Biophys Res Commun; 1979 Jul; 89(1):286-93. PubMed ID: 475814
[No Abstract] [Full Text] [Related]
37. [Activity of substances with sterol nucleus on carbohydrate metabolism. II. Effects of administration of vitamin D2 and vitamin D3].
BAZZI U
Boll Soc Ital Biol Sper; 1951 Jun; 27(6):1092-4. PubMed ID: 14895716
[No Abstract] [Full Text] [Related]
38. Antiproliferative Effects of 1α-OH-vitD
Spath L; Ulivieri A; Lavra L; Fidanza L; Carlesimo M; Giubettini M; Narcisi A; Luciani E; Bucci B; Pisani D; Sciacchitano S; Bartolazzi A
Sci Rep; 2017 Jan; 7():40370. PubMed ID: 28074906
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D status in different subgroups of British Asians.
Hunt SP; O'Riordan JL; Windo J; Truswell AS
Br Med J; 1976 Dec; 2(6048):1351-4. PubMed ID: 1000229
[TBL] [Abstract][Full Text] [Related]
40. 25-Hydroxyvitamin D3 regulation.
Clark MB; Potts JT
Calcif Tissue Res; 1977 May; 22 Suppl():29-34. PubMed ID: 199330
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
